Avalanche Biotechnologies' Series A - II Round

Avalanche Biotechnologies raised a round of funding on November 23, 2013.

Founded in 2006, Avalanche is a publicly traded (AAVL) biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related …

Articles about Avalanche Biotechnologies' Series A - II Round: